Feedback / Questions
ENV-501 - Endeavor BioMed
https://www.globenewswire.com/news-release/2026/01/06/3213347/0/en/Hummingbird-Bioscience-Announces-First-Patient-Dosed-in-Phase-I-Clinical-Trial-of-HMBD-501-in-Advanced-HER3-Expressing-Solid-Malignancies.html
Jan 6, 2026
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Next